![Jeffrey Silber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 579 662 $ in data 31/07/2026
Jeffrey Silber currently works at Ironwood Pharmaceuticals, Inc., as Head-Research & Drug Development from 2026.
Dr. Silber also formerly worked at Vedanta Biosciences, Inc., as Chief Medical Officer from 2020 to 2026.
Dr. Silber received his undergraduate degree from Harvard University and doctorate degree from Albert Einstein College of Medicine, Inc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/07/2026 | 137.036 ( 0,08% ) | 579 662 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 20/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Direttore Tecnico/Scientifico/R&S | 01/07/2026 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
